SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001214659-24-001200
Filing Date
2024-01-25
Accepted
2024-01-25 17:21:29
Documents
2
Group Members
AULT ALLIANCE, INC.AULT LENDING, LLCAULT LIFE SCIENCES FUND, LLCAULT LIFE SCIENCES, INC.DAVID J. KATZOFFHENRY C.W. NISSERKENNETH S. CRAGUNWILLIAM B. HORNE

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 o125241sc13da4.htm SC 13D/A 202304
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 39136
  Complete submission text file 0001214659-24-001200.txt   243121
Mailing Address 11411 SOUTHERN HIGHLANDS PARKWAY SUITE 240 LAS VEGAS NV 89141
Business Address
AULT MILTON C III (Filed by) CIK: 0001212502 (see all company filings)

State of Incorp.: DE
Type: SC 13D/A

Mailing Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326
Business Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326 844-722-6333
Alzamend Neuro, Inc. (Subject) CIK: 0001677077 (see all company filings)

IRS No.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: SC 13D/A | Act: 34 | File No.: 005-92615 | Film No.: 24563261
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)